{
 "PrintNo":"A7550","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2019-05-09T13:44:39.602357Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-05-09","Chamber":"ASSEMBLY"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY"}
 ],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Adds tianeptine sodium to the list of Schedule II of controlled substances",
 "Summary":"Adds tianeptine sodium to list of Schedule II of controlled substances.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances",
 "SameAsPrintNo":"S8023-2019"
}